Human IGF-II/IGF2 Antibody Summary
Ala25-Glu91
Accession # P01344.1
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of Human IGF-II/IGF2 by Western Blot. Western blot shows lysates of human liver tissue, Huh-7 human hepatoma cell line, and HepG2 human hepatocellular carcinoma cell line. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human IGF-II/IGF2 Monoclonal Antibody (Catalog # MAB2921) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for IGF-II/IGF2 at approximately 22 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
View Larger
Detection of IGF-II/IGF2 by Western Blot The MYOD1-mediated IGF2 gene expressions and cell viability. (A,B) mRNA and protein expression levels of MYOD1 in CEFs overexpressing distinct siRNAs. (C) Proliferation analysis of MYOD1-silenced CEF cells. CEF cells transfected with MYOD1 siRNAs were harvested at 48 hpt for CCK-8 assay. (D,E) RT-qPCR and western blot analysis of gga-miR-223 and IGF2 expressions in MYOD1-silenced CEF cells at 48 hpt. (F,G) Expression levels of gga-miR-223, MYOD1, and IGF2 proteins in CEFs overexpressing miR-M2-5p determined by RT-qPCR or western blot analysis. (H) Relative signal intensities in western blot analysis of the MYOD1 and IGF2 proteins in CEFs overexpressing miR-M2-5p. (I,J) Expression levels of gga-miR-223, MYOD1, and IGF2 proteins in GaHV-2-infected CEFs determined by RT-qPCR or western blot analysis. (K) Relative signal intensities in western blot analysis of the MYOD1 and IGF2 proteins in GaHV-2-infected CEFs. Numbers were normalized to the corresponding signal from the beta -actin bands. Error bars are derived from three independent replicates. Values of p indicated on columns were used for statistical analyses; ns, no significance. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33224130), licensed under a CC-BY license. Not internally tested by R&D Systems.
View Larger
Detection of IGF-II/IGF2 by Western Blot Proliferation and apoptosis of miR-M2-5p inhibitor-transfected MSB-1 cells. (A) RT-qPCR analysis of the relative expression levels of viral protein-coding or miRNA genes in MSB-1 cells at 24 hpt with miR-M2-5p inhibitor. (B,C) Cell viability and apoptosis of the MSB-1 cells transfected with miR-M2-5p inhibitor. MSB-1 cells transfected with miR-M2-5p inhibitor were harvested at 24 hpt for Annexin V-FITC and propidium iodide (PI) staining for apoptosis analysis using flow cytometry. CCK-8 assay was used to assess cell viability. (D) Western blot analysis of proteins associated with the cell proliferation or apoptosis in MSB-1 cells at 24 hpt. Numbers below the blots indicate relative band intensity normalized to beta -actin. Error bars are derived from three independent replicates. Values of p indicated on columns were used for statistical analyses; ns, no significance. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33224130), licensed under a CC-BY license. Not internally tested by R&D Systems.
View Larger
Detection of IGF-II/IGF2 by Western Blot The MYOD1-mediated IGF2 gene expressions and cell viability. (A,B) mRNA and protein expression levels of MYOD1 in CEFs overexpressing distinct siRNAs. (C) Proliferation analysis of MYOD1-silenced CEF cells. CEF cells transfected with MYOD1 siRNAs were harvested at 48 hpt for CCK-8 assay. (D,E) RT-qPCR and western blot analysis of gga-miR-223 and IGF2 expressions in MYOD1-silenced CEF cells at 48 hpt. (F,G) Expression levels of gga-miR-223, MYOD1, and IGF2 proteins in CEFs overexpressing miR-M2-5p determined by RT-qPCR or western blot analysis. (H) Relative signal intensities in western blot analysis of the MYOD1 and IGF2 proteins in CEFs overexpressing miR-M2-5p. (I,J) Expression levels of gga-miR-223, MYOD1, and IGF2 proteins in GaHV-2-infected CEFs determined by RT-qPCR or western blot analysis. (K) Relative signal intensities in western blot analysis of the MYOD1 and IGF2 proteins in GaHV-2-infected CEFs. Numbers were normalized to the corresponding signal from the beta -actin bands. Error bars are derived from three independent replicates. Values of p indicated on columns were used for statistical analyses; ns, no significance. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33224130), licensed under a CC-BY license. Not internally tested by R&D Systems.
View Larger
Detection of IGF-II/IGF2 by Western Blot The MYOD1-mediated IGF2 gene expressions and cell viability. (A,B) mRNA and protein expression levels of MYOD1 in CEFs overexpressing distinct siRNAs. (C) Proliferation analysis of MYOD1-silenced CEF cells. CEF cells transfected with MYOD1 siRNAs were harvested at 48 hpt for CCK-8 assay. (D,E) RT-qPCR and western blot analysis of gga-miR-223 and IGF2 expressions in MYOD1-silenced CEF cells at 48 hpt. (F,G) Expression levels of gga-miR-223, MYOD1, and IGF2 proteins in CEFs overexpressing miR-M2-5p determined by RT-qPCR or western blot analysis. (H) Relative signal intensities in western blot analysis of the MYOD1 and IGF2 proteins in CEFs overexpressing miR-M2-5p. (I,J) Expression levels of gga-miR-223, MYOD1, and IGF2 proteins in GaHV-2-infected CEFs determined by RT-qPCR or western blot analysis. (K) Relative signal intensities in western blot analysis of the MYOD1 and IGF2 proteins in GaHV-2-infected CEFs. Numbers were normalized to the corresponding signal from the beta -actin bands. Error bars are derived from three independent replicates. Values of p indicated on columns were used for statistical analyses; ns, no significance. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33224130), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IGF-II/IGF2
Insulin-like growth factor I (also known as somatomedin C and somatomedin A) and insulin-like growth factor II (multiplication stimulating activity or MSA) belong to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGF-I and IGF-II share approximately 70% sequence identity. Both IGF-I and IGF-II are expressed in many tissues and cell types and may have autocrine, paracrine and endocrine functions. Mature IGF-I and IGF-II are highly conserved (100% identity between human, bovine and porcine proteins) and exhibit cross-species activity. IGF-II is a potent mitogenic growth factor. However, unlike IGF-I which has important postnatal roles, the growth-promoting function of IGF-II is limited to embryonic development. Two specific cell surface receptors that bind IGF-I and IGF-II have been identified. The type I IGF receptor that participates in IGF signaling is structurally related to the insulin receptor. It is a disulfide-linked heterotetrameric transmembrane glycoprotein with an intracellular tyrosine kinase domain. Type I IGF receptor binds IGF-I with higher affinity than IGF-II. The type II IGF receptor which binds IGF-II with much higher affinity than IGF-I is also the cation-independent mannose 6-phosphate receptor. At the present time, it is not known if the type II IGF receptor participates in the IGF signaling pathway. An additional unknown receptor which mediates IGF‑II signaling has also been proposed. Circulating IGFs exist in complexes bound to IGF binding proteins. Currently, at least six high affinity binding proteins have been identified.
Product Datasheets
Citation for Human IGF-II/IGF2 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease
Authors: Olivier Govaere, Simon Cockell, Matthias Van Haele, Jasper Wouters, Wouter Van Delm, Kathleen Van den Eynde et al.
The Journal of Pathology
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human IGF-II/IGF2 Antibody
There are currently no reviews for this product. Be the first to review Human IGF-II/IGF2 Antibody and earn rewards!
Have you used Human IGF-II/IGF2 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
